ABSTRAm. Ontogenic changes in the mRNA levels of epidermal growth factor (EGF), transforming growth factor-a, EGF receptor, and thyroid hormone receptor (rerbA) were examined in developing rat kidneys. The mRNA levels of both EGF and thyroid hormone receptor rose dramatically during the postnatal period with the rise in thyroid hormone receptor message preceding the rise in EGF message. In addition, we examined renal mRNA levels in 1-wk-old rats treated with thyroxine (T4) from birth through d 6. Neonatal T4 treatment augmented the renal mRNA levels of EGF but decreased the levels of EGF-receptor and transforming growth factor-a. T4 treatment did not significantly affect the levels of renal mRNA for thyroid hormone receptor. Although the EGF and transforming growth factor-a peptides are similar and interact with the same receptor, our findings indicate that these homologous growth factors are regulated differently during development. In addition, hormones that influence growth and development, such as T4, may function both as positive and negative regulators of growth factor expression. (Pediatr Res 31: 330-334, 1992) born rodents (5, 6), and it has been proposed that EGF mediates these developmental effects of thyroid hormone (7).
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Thyroid hormones also have been shown to increase EGF as well as EGF mRNA levels in developing rodent kidneys (8) . To more fully understand the interrelations among these polypeptide growth factors and thyroid hormones in developing rodent kidney, cDNA probes for EGF, TGF-a, EGF-R, and thyroid hormone receptor (r-erbA-P) were used to examine normal rat kidneys taken from animals ranging in age from 21 d postconception to adult. Northern blots were prepared and used to quantify changes in the relative amount of each message during development. The ontogenic changes in message levels were examined with respect to the normal postnatal increase in T4 secretion. In addition, newborn animals were injected with T4 for the first 6 d of life to prematurely increase circulating adult T4 levels. Northern blots prepared from the kidneys of treated and control animals were examined to determine the effect of T4 treatment on the message levels of EGF, TGF-a, EGF receptor, and thyroid hormone receptor.
MATERIALS AND METHODS

Abbreviations
Sprague-Dawley rats were obtained from Simonson Laboratories. Date-bred rats from the same source provided the fetal EGF, epidermal growth factor and neonatal animals used in the study. The animals were TGF-a, transforming growth factor-a maintained in accordance with the NIH Guide for the Care and EGF-R, epidermal growth factor receptor Use of Laboratory Animals. For the T4 treatment studies, new-SSC, saline sodium citrate born rats were treated with T4 (0.4 yg/g body wt/d) from the day T3, triiodothronine of birth through d 6 of life; kidneys were collected on d 7. After T4, thyroxine decapitation, rat kidney tissues were removed, quickly frozen in poly A+, polyadenylated a bath of liquid nitrogen, and stored at -70°C. Before RNA extraction, the pooled kidney tissue was again placed in liquid nitrogen and ground into a coarse powder with a mortar and pestle. RNA was extracted from 100 mg of the powder using RNAzol (CINNA-BIOTECX, TX). Each extraction yielded Rat EGF and TGF-CY are polypeptide growth factors that share about 100 Pg of total RNA as assayed by abs~rbance at 260 nm. 40% amino acid sequence homology (1,2). In vitro, both growth P O~Y A+ RNA was subsequently prepared by Passage of the total factors function as mitogens as well as differentiation factors for RNA preparations over oligo-dT columns; 0.5-1.0 mg of total a wide variety of epithelial cells, and in vivo they accelerate RNA was passed through 1-mL oligo-dT columns, and P O~Y A+ several developmental processes such as tooth eruption and RNA was eluted with 10 mM Tris (pH 7.2) and 0.3% SDS as eyelid opening (2) (3) (4) . Tooth eruption and eyelid opening can described by Gielen et al. (9) . also be elicited by administration of thyroid hormones to newTo produce Northern blots, 1-3 pg of P O~Y A+ RNA (or 10-15 pg of total RNA) was denatured with glyoxal(50% DMSO, 1 33 1 ribosomal RNA bands and poly A+ gels for the absence of ribosomal RNA bands by staining the gels for 15 min in 0.5 @g/ mL ethidium bromide and then viewing the gels on a UV transilluminator. The RNA was then blotted for 12-20 h to nylon membranes (MSI) with 20 X SSC. These conditions were sufficient to transfer both of the ethidium-stained ribosomal RNA bands from the total RNA gels to the filters. Blots were baked for 2 h at 80°C before hybridization.
Probes specific to four RNA transcripts were used in these experiments. In addition, a single-stranded oligo-dT probe was used to assay for loading inequities on the poly A+ blots. The EGF probe consisted of a 3.3-kb EcoRI fragment of the rat EGF precursor cDNA (1 1). The TGF-a probe was a 2.3-kb EcoRI fragment of the rat TGF-a cDNA described by Blasbland et al. (12) . The EGF-R probe was a 2.2-kb EcoRI cDNA fragment that encodes the entire extracellular domain of the rat EGF-R (1 3). The thyroid hormone receptor probe was a 1.44-kb PstI fragment taken from the 5' coding region of r-erbA-P (14) . The oligo-dT probe (Sigma Chemical Co., St. Louis, MO) was a single-strand polymer 14-22 bases in length.
The gene-specific DNA probes were labeled using 3'P-deoxycytidine triphosphate, random primers, and Klenow fragment (Multiprime; Amersham, Arlington Heights, IL). Typically, 50 ng of fragment yielded 4-8 x lo7 of precipitable counts, which were used for individual hybridizations. The oligonucleotide probe, polythymidilic acid, was 5' end-labeled with y-32P-ATP and polynucleotide kinase (New England Nuclear, Boston, MA); typically, 32 pmol of the oligonucleotide were labeled to 2-4 x lo6 cpm/pmol and the entire yield was used in hybridizations.
Hybridization and washing conditions were those described by the membrane manufacturer (MSI) for perfect hybrids. Prehybridizations were 4 h at 42°C in 50% formamide, 5 x Denhardt's, 5 x SSPE (sodium chloride, sodium phosphate, EDTA), 0.1 % SDS, and 200 @g/rnL carrier DNA. Hybridizations were overnight at 42°C in 50% formamide, 5 x Denhardt's, 5 x SSPE, 0.1 % SDS, 5% dextran sulfate, and 200 pg/mL canier DNA. Hybridization was followed by three washes in 2 x SSC, 5 min each at 22°C; two washes in 2 X SSC and 0.5% SDS, 15 min each at 50°C; and two washes in 0.1 X SSC for 5 min each at 22°C. When it was necessary to rehybridize a blot with a second probe, the blot was heated to 70°C in 500 mL of 5 mM Tris, pH 8.0,0.2 mM EDTA, 0.5% pyrophosphate, and 0.1 x Denhardt's for 2 h to remove any remaining undecayed probe.
Autoradiographs were made by using the blots to expose Kodak X-Omat film at -70°C. Densitometry was performed and analyzed using a video densitometer (model 620; Bio-Rad Laboratories, Richmond, CA) and 1 DPACK software.
Because of the marked developmental change in the amount of EGF RNA in the neonatal rat kidney, it was not practical to use densitometry to quantify relative mRNA levels at various ages. Thus, blots were autoradiographed to determine the exact location of the lanes. The lanes were then cut out, immersed in scintillation cocktail, and counted.
RESULTS
RNA was extracted from the kidneys of rats ranging in age from 21 d postconception to over 80 d postconception (birth occurs at 22 d postconception). Equal amounts of RNA from each age were sized on agarose gels, and Northern blots were prepared. Figure 1 shows a sequence generated from total RNA. The ethidium bromide-stained gel shown in Figure 1A provides visual assurance that all lanes were loaded evenly. A blot prepared from the gel shown in Twelve pg of total rat kidney RNA collected at the indicated ages and rat liver RNA were electrophoresed on a I % agarose gel. The ethidium bromide-stained gel is shown in A. The gel was blotted to a nylon filter and sequentially hybridized with two different probes: B, hybridization with an EGF probe. and C, hybridization with a thyroid hormone receptor probe (r-erbA-8).
increase during the early postnatal period. Blots similar to those shown in Figure 1 were also hybridized with both rat TGF-a and rat EGF-R probes. Hybridizations with either probe could only be visualized after relatively long exposures, and no changes in the levels of these messages were observed (data not shown).
Rat liver RNA was included on the kidney ontogeny blots for comparison. Although the levels of EGF-R message remained constant in developing rat kidney, the amount of EGF message in rat kidney was much less than that in rat liver. In addition, the pattern of hybridization in kidney was different from that in liver. Figure 2 compares equivalent amounts of poly A+ RNA from kidney and liver. Four species (9.6, 6.5, 5.0, and 2.7 kb) of EGF-R RNA have been reported in liver, with the 2.7-kb band being predominant (1 3). The 2.7-kb band is of interest because it encodes a truncated EGF-R; proteins produced from this transcript would lack the transmembrane region. All four EGF receptor RNA species were significantly lower in kidney compared with liver. Also, the 2.7-kb band is the most prominent band in liver, whereas it is relatively reduced in kidney.
Data from blots examined with probes for EGF and thyroid hormone receptor (Fig. 1) were compiled and plotted in Figure  3 . The message levels were compared with the normal developmental increase in serum T4 concentration (15) . TGF-a and EGF-R message levels do not change during postnatal development (data not shown). The graph shows that the relative amounts of message for both EGF and thyroid hormone receptor rise rapidly in rat kidney after birth. and, for both, most of the increase occurs during the 2nd wk of life. The increase in thyroid hormone receptor RNA levels precedes the increase in rat serum T4 levels. EGF message levels also increase rapidly at nearly the same time as serum T4 levels, but rather than reaching a plateau they continue to increase, at a reduced rate, after 30 d of age. To further examine the relationship between serum T4 levels and the levels of the respective messages in developing rat kidney, T4 was injected into newborn rats during the first 6 d of life and the kidneys were examined on d 7. The T4 dose was sufficient to raise the neonatal serum T4 levels to adult values (16) . This represents an overall increase in serum T4 concentration in the 7-d-old animals of about 5-fold. A comparison of the various message levels in control and T4-treated rat kidneys is shown in Figure 4 . Although there was a significant increase in the EGF message levels in the treated animals, the increase was less than 3-fold. During normal development, the increase in EGF levels between d 7 and d 30 is 8-fold. EGF-R and TGF-a message levels showed decreases that were significant at p < 0.01. The decrease in thyroid hormone receptor message level was not significant. 
DISCUSSION
Previously, we localized EGF and TGF-a in rat kidney tubular epithelial cells (17) , and in the current study we have shown that renal EGF mRNA levels are characterized by three ontogenic phases: low levels between fetal d 2 1 and postnatal d 5, a 6-fold increase between d 7 and 21, and a further 2-fold increase between d 21 and 60. These quantitative changes are similar to EGF mRNA ontogenic changes previously observed in mouse kidney (1 8). In rats, a rapid increase in serum T4 occurs during the 2nd wk of life ( I 5) . This, along with the ability of injected T4 to prematurely increase renal EGF mRNA expression in neonatal rats, suggests that the normal postnatal increase in EGF RNA may be regulated by circulating thyroid hormones. This is supported by the finding of a T4-responsive element at the 5' end of cloned mouse EGF cDNA (1 9). This postulated effect of T4 on renal EGF production would require that thyroid hormone receptors be present in kidney tissue on or before d 7. The present results indicate that thyroid hormone receptor message levels have reached about 25% of the maximal value by d 7. We examined only the message levels for r-erbA-P; there is a second form of thyroid hormone receptor, r-erbA-a (20) , that could potentially contribute to available receptors in the developing kidney. The r-erbA-a mRNA levels were not examined because the message levels are relatively low compared with those of rerbA-0, and it has been shown that the r-erbA-0 message levels better correlate with nuclear T j binding in kidney tissue (21) .
In rats, a rapid phase of renal growth (i.e. cell division) occurs between fetal life and postnatal d 15 (22) , and functional maturation (i.e. differentiation) has been observed between postnatal d 12 and 30 (23, 24) . The lack of significant changes in EGF mRNA expression during the rapid growth phase and the large increase in EGF message that accompanies the period of maturational changes suggest that the translated precursor or the precursor-derived proteins may play an important role in renal tubular functional maturation. In rat as well as mouse and human kidneys, EGF immunoreactivity is localized to the apical membrane of the tubular cell, suggesting that the peptide is synthesized and stored as a transmembrane precursor protein (25) . Preliminary investigations also show that rat kidney is similar to mouse and human kidney in that it secretes proEGF and partially processed high molecular weight EGF into urine (26) . Whether the precursor or processed proteins function as maturation factors is presently under investigation in this laboratory.
Only a small amount of TGF-a mRNA is found in kidney extracts, and, in contrast to EGF mRNA, the TGF-a mRNA levels were constant in all age groups studied. The lack of ontogenic changes in TGF-a mRNA concentrations was unexpected because we have observed age-dependent changes in renal TGF-a immunoreactivity (27) . This peptide-mRNA discrepancy could relate to mRNA stability, protein storage pools, or developmental changes in the renal TGF-a precursor processing enzyme(~). At present, little information is available on the processing of proTGF-a in vivo.
T4 treatment of newborn rats increased the levels of EGF message but caused a significant decrease in the level of TGF-a message. In rat kidney, TGF-a is expressed in the cortical collecting tubular cells (17) . The differential effects of T4 on EGF and TGF-a messages suggest that T4 may have distinct effects on different nephron segments that express specific growth factors. Although the 5' flanking region of the TGF-(Y gene does not contain a thyroid hormone responsive element, a recent study reported a stimulatory effect of T3 on TGF-a mRNA expression in human mammary carcinoma cells (28) . The observed decreases in renal TGF-a message levels in T4-treated animals suggest that inhibition may be mediated by other factors. The possibility that proEGF or its processed proteins participate in the inhibition cannot be ruled out inasmuch as these growth factors, in urine, are expected to make contact with cortical collecting tubular cells.
In the present study, we observed that EGF-R mRNA is present in rat kidneys at a low, constant level during the fetal, neonatal, and adult stages of development. There have been no previous investigations regarding the ontogeny of renal EGF-R mRNA in any species. However, renal EGF-R distribution has been investigated in mouse, rat, rabbit, and man (29-34). Radioactive ligand binding studies in mice indicate that EGF-R are present only during a restricted period of fetal development (29). In contrast, both ligand-binding studies and biologic response studies in rats and rabbits provide evidence for the presence of EGF-R in adult kidneys (30, 31). Ligand-binding studies with human fetal kidney membranes and the presence of EGF-R mRNA in adult human kidney suggest that EGF-R are present during both fetal and adult stages of development (32, 33).
T4 treatment of I-wk-old rats caused a significant decrease in EGF-R mRNA expression. A T j receptor element in the EGF-R 5' promoter region has recently been identified, and negative regulation by ligand-activated T j receptor has been reported (35). The observed inhibitory response in this study is consistent with the reported inhibitory role of thyroid hormones in EGF-R expression. Finally, with respect to possible feedback controls of EGF and EGF-R synthesis, it is interesting to note that in both kidney and liver tissue there is an inverse relationship between the level of EGF and EGF-R messages. In adult rats, EGF message levels in kidney are high compared with those in liver. The opposite is true with the EGF-R message; levels are low in kidney and high in liver. These data suggest that EGF synthesized in a tissue may not act directly on EGF-R in the same tissue. A mechanism or mechanisms may exist that prevent the colocalization of EGF and EGF-R, thereby limiting the possibility of uncontrolled cell proliferation. 
NIH Treatment Study for Sydenham's Chorea
Acutely ill patients with Sydenham's chorea are being sought for a controlled treatment study. Eligible patients will receive free diagnostic evaluation and treatment, including palliative medications, at the Child Psychiatry Branch of the National Institute of Mental Health in Bethesda, MD. The treatment study is an outgrowth of our long-term investigations of the sequelae of Sydenham's chorea. To participate, children should be at least 6 y old and acutely ill. There will be izo esyense to the patient (all treatment, travel, and lodging will be free of cost) and no remuneration. To refer a patient, contact Dr. Susan Swedo at (30 1) 496-608 1, Building 10, Room 6N240, 9000 Rockville Pike, Bethesda, MD 20892, FAX (301) 402-0296.
